Cargando…
Essential role of endogenous prolactin and CDK7 in estrogen-induced upregulation of the prolactin receptor in breast cancer cells
Our early studies have shown that Estradiol (E(2))/Estrogen Receptor α (ER) in a non-DNA dependent manner through complex formation with C/EBPβ/SP1 induced transcriptional activation of the generic hPIII promoter and expression of the Prolactin Receptor (PRLR) receptor in MCF-7 cells. Subsequent stu...
Autores principales: | Kavarthapu, Raghuveer, Dufau, Maria L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432340/ https://www.ncbi.nlm.nih.gov/pubmed/28423697 http://dx.doi.org/10.18632/oncotarget.16040 |
Ejemplares similares
-
Role of EGF/ERBB1 in the transcriptional regulation of the prolactin receptor independent of estrogen and prolactin in breast cancer cells
por: Kavarthapu, Raghuveer, et al.
Publicado: (2016) -
Prolactin receptor gene transcriptional control, regulatory modalities relevant to breast cancer resistance and invasiveness
por: Kavarthapu, Raghuveer, et al.
Publicado: (2022) -
Prolactin induces up-regulation of its cognate receptor in breast cancer cells via transcriptional activation of its generic promoter by cross-talk between ERα and STAT5
por: Kavarthapu, Raghuveer, et al.
Publicado: (2014) -
The role of Prolactin/Prolactin Receptor polymorphisms and expression in breast cancer susceptibility and outcome
por: Sa-nguanraksa, Doonyapat, et al.
Publicado: (2020) -
The Expression of Prolactin Receptors in Benign Breast Tumors Is Not Associated with Serum Prolactin Level
por: Kolomiiets, Olena, et al.
Publicado: (2021)